☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025, OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ________________
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.01 par value
MTD
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No☐
Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes☒ No ☐
Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer.☒Accelerated filer☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No☒
The Registrant had 20,599,040 shares of Common Stock outstanding at June 30, 2025.
Trade accounts receivable, less allowances of $15,881 at June 30, 2025
and $16,657 at December 31, 2024
681,598
687,112
Inventories
388,081
342,274
Other current assets and prepaid expenses
112,957
105,158
Total current assets
1,244,461
1,193,906
Property, plant and equipment, net
817,419
770,280
Goodwill
684,122
668,914
Other intangible assets, net
253,528
257,143
Deferred tax assets, net
37,093
34,586
Other non-current assets
363,842
315,170
Total assets
$
3,400,465
$
3,239,999
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Trade accounts payable
$
216,188
$
215,843
Accrued and other liabilities
188,983
187,701
Accrued compensation and related items
159,346
184,532
Deferred revenue and customer prepayments
243,826
204,166
Taxes payable
238,362
193,328
Short-term borrowings and current maturities of long-term debt
60,187
182,623
Total current liabilities
1,106,892
1,168,193
Long-term debt
2,123,735
1,831,265
Deferred tax liabilities, net
115,088
103,953
Other non-current liabilities
313,543
263,478
Total liabilities
3,659,258
3,366,889
Commitments and contingencies (Note 14)
Shareholders’ equity:
Preferred stock, $0.01 par value per share; authorized 10,000,000 shares
—
—
Common stock, $0.01 par value per share; authorized 125,000,000 shares; issued 44,786,011 and 44,786,011 shares; outstanding 20,599,040 shares and 20,949,461 shares at June 30, 2025 and December 31, 2024, respectively
448
448
Additional paid-in capital
911,147
897,025
Treasury stock at cost (24,186,971 shares at June 30, 2025 and 23,836,550 shares at December 31, 2024)
(9,486,086)
(9,049,925)
Retained earnings
8,737,339
8,371,420
Accumulated other comprehensive loss
(421,641)
(345,858)
Total shareholders' equity
(258,793)
(126,890)
Total liabilities and shareholders’ equity
$
3,400,465
$
3,239,999
The accompanying notes are an integral part of these interim consolidated financial statements.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
1.BASIS OF PRESENTATION
Mettler-Toledo International Inc. (Mettler-Toledo or the Company) is a leading global supplier of precision instruments and services. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications. The Company also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development. In addition, the Company manufactures metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications. The Company's primary manufacturing facilities are located in China, Germany, Switzerland, the United Kingdom, the United States and Mexico. The Company's principal executive offices are located in Columbus, Ohio and Greifensee, Switzerland.
The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include all entities in which the Company has control, which are its wholly-owned subsidiaries. The interim consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
The accompanying interim consolidated financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results of the interim periods presented. Operating results for the three and six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year ending December 31, 2025.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. These financial statements were prepared using information reasonably available as of June 30, 2025 and through the date of this report. Actual results may differ from those estimates due to uncertainty around ongoing developments related to global trade/tariffs, governmental policies, and the conflicts in Ukraine and the Middle East, as well as other factors.
All intercompany transactions and balances have been eliminated.
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Trade Accounts Receivable
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for expected credit losses represents the Company’s best estimate based on historical information, current information, and reasonable and supportable forecasts of future events and circumstances.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Inventories
Inventories are valued at the lower of cost or net realizable value. Cost, which includes direct materials, labor and overhead, is generally determined using the first in, first out (FIFO) method. The estimated net realizable value is based on assumptions for future demand and related pricing. Adjustments to the cost basis of the Company’s inventory are made for excess and obsolete items based on usage, orders and technological obsolescence. If actual market conditions are less favorable than those projected by management, reductions in the value of inventory may be required in the future.
Inventories consisted of the following:
June 30, 2025
December 31, 2024
Raw materials and parts
$
179,788
$
161,416
Work-in-progress
79,042
69,488
Finished goods
129,251
111,370
$
388,081
$
342,274
Goodwill and Other Intangible Assets
Goodwill, representing the excess of purchase price over the net asset value of companies acquired, and indefinite-lived intangible assets are not amortized, but are reviewed for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that an asset might be impaired. The annual evaluation for goodwill and indefinite-lived intangible assets are generally based on an assessment of qualitative factors to determine whether it is more likely than not that the fair values of the assets are less than their carrying amounts.
Other intangible assets include indefinite-lived assets and assets subject to amortization. Where applicable, amortization is charged on a straight-line basis over the expected period to be benefited. The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the Company in each reporting period. The Company assesses the initial acquisition of intangible assets in accordance with the provisions of ASC 805 "Business Combinations" and the continued accounting for previously recognized intangible assets and goodwill in accordance with the provisions of ASC 350 "Intangibles - Goodwill and Other" and ASC 360 "Property, Plant and Equipment".
Other intangible assets consisted of the following:
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The Company recognized amortization expense associated with the above intangible assets of $6.6 million and $6.7 million for the three months ended June 30, 2025 and 2024, respectively, and $13.2 million and $13.6 million for the six months ended June 30, 2025 and 2024, respectively. The annual aggregate amortization expense based on the current balance of other intangible assets is estimated to be $27.4 million for 2025, $24.4 million for 2026, $23.6 million for 2027, $21.0 million for 2028, $19.0 million for 2029, and $18.1 million for 2030. Purchased intangible amortization was $6.5 million, $5.0 million after tax, and $6.5 million, $5.0 million after tax, for the three months ended June 30, 2025 and 2024, respectively, and $12.8 million, $9.9 million after tax, and $13.1 million, $10.1 million after tax, for the six months ended June 30, 2025 and 2024, respectively.
In addition to the above amortization, the Company recorded amortization expense associated with capitalized software of $10.9 million and $11.4 million for the three months ended June 30, 2025 and 2024, respectively, and $21.4 million and $22.7 million for the six months ended June 30, 2025 and 2024, respectively.
Revenue Recognition
Product revenue is recognized from contracts with customers when a customer has obtained control of a product. The Company considers control to have transferred based upon shipping terms. To the extent the Company’s arrangements have a separate performance obligation, revenue related to any post-shipment performance obligation is deferred until completed. Shipping and handling costs charged to customers are included in total net sales and the associated expense is a component of cost of sales. Certain products are also sold through indirect distribution channels whereby the distributor assumes any further obligations to the end customer. Revenue is recognized on these distributor arrangements upon transfer of control to the distributor. Contracts do not contain variable pricing arrangements that are retrospective, except for rebate programs. Rebates are estimated based on expected sales volumes and offset against revenue at the time such revenue is recognized. The Company generally maintains the right to accept or reject a product return in its terms and conditions and also maintains appropriate accruals for outstanding credits. The related provisions for estimated returns and rebates are immaterial to the consolidated financial statements.
Certain of the Company’s product arrangements include separate performance obligations, primarily related to installation. Such performance obligations are accounted for separately when the deliverables have stand-alone value and the satisfaction of the undelivered performance obligations is probable and within the Company's control. The allocation of revenue between the performance obligations is based on the observable stand-alone selling prices at the time of the sale in accordance with a number of factors including service technician billing rates, time to install, and geographic location.
Software is generally not considered a distinct performance obligation with the exception of a limited number of software applications. The Company primarily sells software products with the related hardware instrument as the software is embedded in the product. The Company’s products typically require no significant production, modification, or customization of the hardware or software that is essential to the functionality of the products.
Service revenue not under contract is recognized upon the completion of the service performed. Revenue from spare parts sold on a stand-alone basis is recognized when control is transferred to the customer, which is generally at the time of shipment or delivery. Revenue from service contracts is recognized ratably over the contract period using a time-based method. These contracts represent an obligation to perform repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance on a customer’s pre-defined equipment over the contract period.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Share-Based Compensation
The Company recognizes share-based compensation expense within selling, general and administrative in the consolidated statements of operations and other comprehensive income with a corresponding offset to additional paid-in capital in the consolidated balance sheet. The Company recognized $5.4 million and $10.5 million of share-based compensation expense for the three and six months ended June 30, 2025, respectively, compared to $4.5 million and $9.3 million for the corresponding periods in 2024.
Research and Development
Research and development costs primarily consist of salaries, consulting and other costs. The Company expenses these costs as incurred.
Business Combinations and Asset Acquisitions
The Company accounts for business acquisitions under the accounting standards for business combinations using the acquisition method of accounting. The results of each acquisition are included in the Company's consolidated results as of the acquisition date. The purchase price of an acquisition is generally allocated to tangible and intangible assets and assumed liabilities based on their estimated fair values and any consideration in excess of the net assets acquired is recognized as goodwill. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and intangible assets, require significant judgment. Acquisition transaction costs are expensed when incurred.
In circumstances where an acquisition involves a contingent consideration arrangement, the Company recognizes a liability equal to the fair value of the expected contingent payments as of the acquisition date. Subsequent changes in the fair value of the contingent consideration are recorded to other charges (income), net.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07: Improvements to Reportable Segment Disclosures which requires incremental disclosures about a public entity's reportable segments but does not change the definition of a segment or the guidance for determining reportable segments. The Company adopted these annual disclosure requirements on a retrospective basis in 2024. See Note 13 for the quarterly reportable segments disclosures.
In December 2023, the FASB issued ASU 2023-09: Improvements to Income Tax Disclosures, which enhances income tax disclosures, especially related to the rate reconciliation and income taxes paid information. The Company will adopt the annual disclosure requirements in 2025 and is currently evaluating the impact of these requirements on the consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03: Disaggregation of Income Statement Expenses, which requires disclosures about the nature of expenses presented on the face of the income statement. The Company will adopt the annual disclosure requirements in 2027 and is currently evaluating the impact of this guidance on the consolidated financial statements.
3.REVENUE
The Company disaggregates revenue from contracts with customers by product, service, timing of revenue recognition and geography. A summary of revenue by the Company’s reportable segments for the three and six months ended June 30, 2025 and 2024 follows:
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The Company's global revenue mix by product category is laboratory (56% of sales), industrial (39% of sales) and retail (5% of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global revenue mix except the Company's Swiss Operations is largely comprised of laboratory products while the Company's Chinese Operations has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the three and six months ended June 30 is as follows:
Three Months Ended
Six Months Ended
June 30,
June 30,
2025
2024
2025
2024
Laboratory
$
537,916
$
523,233
$
1,038,140
$
1,048,288
Industrial
394,628
374,257
735,828
726,102
Retail
50,677
49,260
92,997
98,309
Total
$
983,221
$
946,750
$
1,866,965
$
1,872,699
The payment terms in the Company’s contracts with customers do not exceed one year and therefore contracts do not contain a significant financing component. In most cases, after appropriate credit evaluations, payments are due in arrears and are recognized as receivables. Unbilled revenue is recorded when performance obligations have been satisfied, but not yet billed to the customer. Unbilled revenue as of June 30, 2025 and December 31, 2024 was $41.2 million and $32.6 million, respectively, and is included within accounts receivable. Deferred revenue and customer prepayments are recorded when cash payments are received or due in advance of the performance obligation being satisfied. Deferred revenue primarily includes prepaid service contracts, as well as deferred installation.
Changes in the components of deferred revenue and customer prepayments during the six month periods ended June 30, 2025 and 2024 are as follows:
2025
2024
Beginning balances as of January 1
$
204,166
$
202,022
Customer pre-payments/deferred revenue
363,588
338,581
Revenue recognized
(335,082)
(320,727)
Foreign currency translation
11,154
(5,671)
Ending balance as of June 30
$
243,826
$
214,205
The Company generally expenses sales commissions when incurred because the contract period is one year or less. These costs are recorded within selling, general, and administrative expenses. The value of unsatisfied performance obligations other than customer prepayments and deferred revenue associated with contracts greater than one year is immaterial.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
4. FINANCIAL INSTRUMENTS
The Company has limited involvement with derivative financial instruments and does not use them for trading purposes. The Company enters into certain interest rate and cross currency swap agreements in order to manage its exposure to changes in interest rates. The amount of the Company's fixed obligation interest payments may change based upon the expiration dates of its interest rate and cross currency swap agreements and the level and composition of its debt. The Company also enters into certain foreign currency forward contracts to limit the Company's exposure to currency fluctuations on the respective hedged items. For additional disclosures on derivative instruments regarding balance sheet location, fair value, and the amounts reclassified into other comprehensive income and the effective portion of the cash flow hedges, also see Note 5 and Note 9 to the interim consolidated financial statements. As also described in Note 7, the Company has designated its euro-denominated debt as a hedge of a portion of its net investment in euro-denominated foreign subsidiaries.
Cash Flow Hedges
The Company has entered into a number of cross currency swaps designated as cash flow hedges. The agreements convert borrowings under the Company’s credit facility into synthetic Swiss franc debt, which allows the Company to effectively change the floating rate SOFR-based interest payments, excluding the credit spread, to a fixed Swiss franc income or expense as follows:
Agreement Date
Amount Converted
Effective Swiss Franc Interest Rate
Maturity Date
June 2019
$50 million
(0.82)%
June 2023
November 2021
$50 million
(0.67)%
November 2023
June 2021
$50 million
(0.73)%
June 2024
June 2021
$50 million
(0.59)%
June 2025
December 2023
$50 million
1.04%
November 2026
November 2023
$50 million
1.16%
November 2026
June 2023
$50 million
1.55%
June 2027
June 2024
$50 million
1.15%
June 2027
June 2025
$50 million
(0.21)%
June 2028
In June 2025, the Company entered into a cross currency swap arrangement, as summarized above, to replace the cross currency swap that matured in June 2025. The new swap was designated as an effective cash flow hedge.
The Company's cash flow hedges are recorded gross at fair value in the consolidated balance sheet at June 30, 2025 and December 31, 2024, respectively. A derivative gain of $5.5 million based upon interest rates at June 30, 2025, is expected to be reclassified from other comprehensive income (loss) to earnings in the next twelve months. The cash flow hedges remain effective as of June 30, 2025.
Other Derivatives
The Company enters into foreign currency forward contracts in order to economically hedge short-term trade and non-trade intercompany balances largely denominated in Swiss franc, other major European currencies, and the Chinese renminbi with its foreign businesses. In accordance with U.S. GAAP, these contracts are considered “derivatives not designated as hedging instruments.” Gains or losses on these instruments are reported in current earnings. The foreign currency forward contracts are recorded at fair value in the consolidated balance sheet at June 30, 2025 and December 31, 2024, as disclosed in Note 5. The Company recognized in other charges (income) a net loss of $12.6 million and $4.2 million during the three months ended June 30, 2025 and 2024, respectively, and a net loss of $11.3
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
million and a net gain of $4.6 million during the six months ended June 30, 2025 and 2024, respectively, which offset the related transaction gains (losses) associated with these contracts. At June 30, 2025 and December 31, 2024, these contracts had a notional value of $859.1 million and $788.6 million, respectively.
5. FAIR VALUE MEASUREMENTS
At June 30, 2025 and December 31, 2024, the Company had derivative assets totaling $2.4 million and $9.2 million respectively, and derivative liabilities totaling $40.1 million and $8.5 million, respectively. The Company has limited involvement with derivative financial instruments and therefore does not present all the required disclosures in tabular format. The fair values of the cross-currency swap agreements and foreign currency forward contracts that economically hedge short-term intercompany balances are estimated based upon inputs from current valuation information obtained from dealer quotes and priced with observable market assumptions and appropriate valuation adjustments for credit risk. The Company has evaluated the valuation methodologies used to develop the fair values by dealers in order to determine whether such valuations are representative of an exit price in the Company’s principal market. In addition, the Company uses an internally developed model to perform testing on the valuations received from brokers. The Company has also considered both its own credit risk and counterparty credit risk in determining fair value and determined these adjustments were insignificant at June 30, 2025 and December 31, 2024.
Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement consists of observable and unobservable inputs that reflect the assumptions that a market participant would use in pricing an asset or liability.
A fair value hierarchy has been established that categorizes these inputs into three levels:
Level 1: Quoted prices in active markets for identical assets and liabilities
Level 2: Observable inputs other than quoted prices in active markets for identical assets and liabilities
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The following table presents the Company's assets and liabilities, which are all categorized as Level 2, that are measured at fair value on a recurring basis. The Company does not have any assets or liabilities which are categorized as Level 1:
June 30, 2025
December 31, 2024
Balance Sheet Classification
Foreign currency forward contracts not designated as hedging instruments
$
2,412
$
7,949
Other current assets and prepaid expenses
Cash Flow Hedges:
Cross currency swap agreement
—
$
855
Other current assets and prepaid expenses
Cross currency swap agreement
—
398
Other non-current assets
Total derivative assets
$
2,412
$
9,202
Foreign currency forward contracts not designated as hedging instruments
$
6,102
$
4,078
Accrued and other liabilities
Cash Flow Hedges:
Cross currency swap agreement
—
—
Accrued and other liabilities
Cross currency swap agreement
33,977
4,463
Other non-current liabilities
Total derivative liabilities
$
40,079
$
8,541
The Company had $5.7 million and $3.7 million of cash equivalents at June 30, 2025 and December 31, 2024, respectively, the fair value of which is determined using Level 2 inputs, through quoted and corroborated prices in active markets. The fair value of cash equivalents approximates cost.
The fair value of the Company's debt is less than the carrying value by approximately $195.8 million as of June 30, 2025. The fair value of the Company's fixed interest rate debt was estimated using Level 2 inputs, primarily discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company.
6. INCOME TAXES
The Company's reported tax rate was 18.6% and 8.8% during the three months ended June 30, 2025 and 2024, respectively and 18.8% and 13.9% during the six months ended June 30, 2025 and 2024, respectively. The provision for taxes is based upon using the Company's projected annual effective tax rate of 19.0% before non-recurring discrete tax items during 2025 and 2024. The difference between the Company's projected annual effective tax rate and the reported tax rate is primarily related to the timing of excess tax benefits associated with stock option exercises. The reported tax rate for the three and six month periods ended June 30, 2024 also includes a non-cash discrete tax benefit of $23.0 million resulting from the reduction of uncertain tax position liabilities related to the settlement of a tax audit.
On July 4, 2025, the United States enacted new tax legislation into law. The Company is currently evaluating the impact of the new legislation on its consolidated financial statements and does not expect a significant impact on its projected annual tax rate.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
7. DEBT
Debt consisted of the following at June 30, 2025:
U.S. Dollar
Other Principal Trading Currencies
Total
3.91% $75 million ten-year Senior Notes due June 25, 2029
75,000
—
75,000
5.45% $150 million ten-year Senior Notes due March 1, 2033
150,000
—
150,000
2.83% $125 million twelve-year Senior Notes due July 22, 2033
125,000
—
125,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035
50,000
—
50,000
2.81% $150 million fifteen-year Senior Note due March 17, 2037
150,000
—
150,000
2.91% $150 million fifteen-year Senior Note due September 1, 2037
150,000
—
150,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030
—
146,285
146,285
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034
—
157,987
157,987
1.06% Euro 125 million fifteen-year Senior Notes due March 19, 2036
—
146,285
146,285
3.80% Euro 100 million 10 1/2-year Senior Notes due July 9, 2035
—
117,028
117,028
Debt issuance costs, net
(2,206)
(1,858)
(4,064)
Total Senior Notes
697,794
565,727
1,263,521
$1.35 billion Credit Agreement, interest at benchmark plus 87.5 basis points (a)
437,637
414,432
852,069
Other local arrangements
9,243
59,089
68,332
Total debt
1,144,674
1,039,248
2,183,922
Less: current portion
(1,306)
(58,881)
(60,187)
Total long-term debt
$
1,143,368
$
980,367
$
2,123,735
(a) The benchmark interest rate is determined by the borrowing currency. The benchmark rates by borrowing currency are as follows: SOFR for U.S. dollars (plus a 10 basis points spread adjustment), SARON for Swiss franc, EURIBOR for Euro and SONIA for Great British pounds.
On May 30, 2024, the Company entered into a $1.35 billion Credit Agreement (the Credit Agreement), which amended its $1.25 billion Amended and Restated Credit Agreement (the Prior Credit Agreement). As of June 30, 2025, the Company had $493.4 million of additional borrowings available under its Credit Agreement, and the Company maintained $61.8 million of cash and cash equivalents.
The Credit Agreement is provided by a group of financial institutions (similar to the Company's Prior Credit Agreement) and has a maturity date of 2029. It is a revolving credit facility and is not subject to any scheduled principal payments prior to maturity. The obligations under the Credit Agreement are unsecured.
Borrowings under the Credit Agreement bear interest at current market rates plus a margin based on the Company’s consolidated leverage ratio. The Company must also pay facility fees that are tied to its leverage ratio. The Credit Agreement contains covenants that are similar to those contained in the prior Credit Agreement, with which the Company was in compliance as of June 30, 2025. The Company is required to maintain (i) a ratio of net funded indebtedness to EBITDA of 3.5 to 1.0 or less, except in certain circumstances and (ii) an interest coverage ratio of 3.0 to 1.0 or greater. The Credit Agreement also places certain limitations on the Company, including limiting the ability to incur liens or indebtedness at a subsidiary level. In addition, the Credit Agreement has several events of default, with customary grace periods applicable.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
In January 2025, the Company entered into an agreement to issue and sell EUR 100 million 10 1/2-year Senior Notes with a fixed interest rate of 3.8% (3.8% Euro Senior Notes) in a private placement, which will mature in July 2035. The 3.8% Euro Senior Notes are unsecured obligations of the Company, and the terms are consistent with the previous Notes as disclosed in Note 10 to the Company's consolidated financial statements for the year ended December 31, 2024. The Company used the proceeds from the sale of the notes to refinance existing indebtedness and for other general corporate purposes.
The Company has designated the EUR 125 million 1.47% Euro Senior Notes, the EUR 135 million 1.30% Euro Senior Notes, the EUR 125 million 1.06% Euro Senior Notes, and the EUR 100 million 3.80% Euro Senior Notes as a hedge of a portion of its net investment in euro-denominated foreign subsidiaries to reduce foreign currency risk associated with the net investment. Changes in the carrying value of this debt resulting from fluctuations in the euro to U.S. dollar exchange rate are recorded as foreign currency translation adjustments within other comprehensive income (loss). The Company recorded in other comprehensive income (loss) related to this net investment hedge an unrealized loss of $44.6 million and unrealized gain of $5.1 million for the three months ended June 30, 2025 and 2024, respectively, and an unrealized loss of $63.8 million and unrealized gain of $13.3 million for the six month periods ended June 30, 2025 and 2024, respectively. The Company has an unrealized loss of $21.5 million recorded in accumulated other comprehensive income (loss) as of June 30, 2025.
Other Local Arrangements
In April 2018, two of the Company's non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions, which include an interest rate of SARON plus 87.5 basis points. The loans were renewed for one year in April 2025.
8. SHARE REPURCHASE PROGRAM AND TREASURY STOCK
The Company has $1.3 billion of remaining availability for its share repurchase program as of June 30, 2025. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors.
The Company has purchased 32.7 million shares at an average price per share of $312.57 since the inception of the program in 2004 through June 30, 2025. During the six months ended June 30, 2025 and 2024, the Company spent $437.5 million and $425.0 million on the repurchase of 368,010 shares and 330,492 shares at an average price per share of $1,188.80 and $1,285.94, respectively. The Company also reissued 17,589 shares and 23,538 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the six months ended June 30, 2025 and 2024, respectively. In addition, the Company incurred $2.1 million and $1.9 million of excise tax during the three months ended June 30, 2025 and 2024, respectively, and $4.1 million and $4.0 million of excise tax during the six months ended June 30, 2025 and 2024, respectively related to the Inflation Reduction Act which is reflected as a reduction in shareholders' equity in the Company's consolidated financial statements.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The following table presents amounts recognized from accumulated other comprehensive income (loss) for the three and six month periods ended June 30:
Three Months Ended
June 30,
2025
2024
Location of Amounts Recognized in Earnings
Effective portion of (gains) losses on cash flow hedging arrangements:
Cross currency swap agreement
$
17,844
$
(670)
(a)
Provision for taxes
3,390
(127)
Provision for taxes
Total, net of taxes
$
14,454
$
(543)
Recognition of defined benefit pension and post-retirement items:
Recognition of actuarial losses and prior service cost, before taxes
$
4,015
$
2,998
(b)
Provision for taxes
792
611
Provision for taxes
Total, net of taxes
$
3,223
$
2,387
(a) The cross currency swap reflects an unrealized loss of $20.0 million for the three months ended June 30, 2025 recorded in other charges (income) that was offset by the underlying unrealized gain on the hedged debt. The cross currency swap also reflects a realized gain of $2.1 million recorded in interest expense for the three months ended June 30, 2025.
(b) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and post-retirement cost. See Note 11 for additional details for the three months ended June 30, 2025 and 2024.
Six Months Ended
June 30,
2025
2024
Location of Amounts Recognized in Earnings
Effective portion of (gains) losses on cash flow hedging arrangements:
Cross currency swap agreement
$
21,879
$
(21,866)
(a)
Provision for taxes
4,157
(4,155)
Provision for taxes
Total, net of taxes
$
17,722
$
(17,711)
Recognition of defined benefit pension and post-retirement items:
Recognition of actuarial losses and prior service cost, before taxes
$
7,760
$
6,106
(b)
Provision for taxes
1,532
1,243
Provision for taxes
Total, net of taxes
$
6,228
$
4,863
(a) The cross currency swap reflects an unrealized loss of $26.2 million for the six months ended June 30, 2025 recorded in other charges (income) that was offset by the underlying unrealized gain on the hedged debt. The cross currency swap also reflects a realized gain of $4.3 million recorded in interest expense for the six months ended June 30, 2025.
(b) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and post-retirement cost. See Note 11 for additional details for the six months ended June 30, 2025 and 2024.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
10. EARNINGS PER COMMON SHARE
In accordance with the treasury stock method, the Company has included the following common equivalent shares in the calculation of diluted weighted average number of common shares outstanding for the three and six months ended June 30, relating to outstanding stock options and restricted stock units:
2025
2024
Three months ended
51,387
113,544
Six months ended
59,177
110,656
Outstanding options and restricted stock units to purchase or receive 100,446 and 60,855 shares of common stock for the three month period ended June 30, 2025 and 2024, respectively, have been excluded from the calculation of diluted weighted average number of common and common equivalent shares as such options and restricted stock units would be anti-dilutive. Options and restricted stock units to purchase or receive 92,116 and 61,532 shares for the six month period ended June 30, 2025 and 2024, respectively, have been excluded from the calculation of diluted weighted average of common and common equivalent shares as such options and restricted stock units would be anti-dilutive.
11. NET PERIODIC PENSION COST
Net periodic pension cost for the Company’s defined benefit pension plans and U.S. post-retirement medical plan includes the following components for the three months ended June 30:
U.S. Pension Benefits
Non-U.S. Pension Benefits
Other U.S. Post-retirement Benefits
Total
2025
2024
2025
2024
2025
2024
2025
2024
Service cost, net
$
233
$
397
$
4,661
$
3,892
$
—
$
—
$
4,894
$
4,289
Interest cost on projected benefit obligations
1,201
1,191
3,823
4,370
6
6
5,030
5,567
Expected return on plan assets
(1,428)
(1,368)
(11,029)
(9,050)
—
—
(12,457)
(10,418)
Recognition of prior service cost
—
—
(1,045)
(1,120)
(19)
(19)
(1,064)
(1,139)
Recognition of actuarial losses/(gains)
393
520
4,689
3,638
8
8
5,090
4,166
Net periodic pension cost/(credit)
$
399
$
740
$
1,099
$
1,730
$
(5)
$
(5)
$
1,493
$
2,465
Net periodic pension cost for the Company’s defined benefit pension plans and U.S. post-retirement medical plan includes the following components for the six months ended June 30:
U.S. Pension Benefits
Non-U.S. Pension Benefits
Other U.S. Post-retirement Benefits
Total
2025
2024
2025
2024
2025
2024
2025
2024
Service cost, net
$
466
$
794
$
9,156
$
7,912
$
—
$
—
$
9,622
$
8,706
Interest cost on projected benefit obligations
2,402
2,383
7,374
8,849
12
13
9,788
11,245
Expected return on plan assets
(2,856)
(2,736)
(21,216)
(18,395)
—
—
(24,072)
(21,131)
Recognition of prior service cost
—
—
(2,004)
(2,281)
(38)
(38)
(2,042)
(2,319)
Recognition of actuarial losses/(gains)
786
1,041
9,013
7,399
16
16
9,815
8,456
Net periodic pension cost/(credit)
$
798
$
1,482
$
2,323
$
3,484
$
(10)
$
(9)
$
3,111
$
4,957
As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, the Company expects to make employer contributions of approximately $25.4 million to its non-U.S. pension plans during the year ended December 31, 2025. This estimate may change based
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
upon several factors, including fluctuations in currency exchange rates, actual returns on plan assets and changes in legal requirements.
12. OTHER CHARGES (INCOME), NET
Other charges (income), net includes non-service pension costs (benefits), (gains) losses from foreign currency transactions and related hedging activities, interest income and other items. Non-service pension benefits were $3.4 million and $1.9 millionfor the three month periods ended June 30, 2025 and 2024, respectively, and $6.5 million and $3.8 million for the six month periods ended June 30, 2025 and 2024, respectively.
13. SEGMENT REPORTING
As disclosed in Note 18 to the Company's consolidated financial statements for the year ended December 31, 2024, the Company has determined there are five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other.
Our reportable segments comprise the structure used by our Chief Executive Officer, who is our Chief Operating Decision Maker (CODM), to make key operating decisions and assess performance. The Company evaluates performance based on segment profit for segment reporting (gross profit less research and development and selling, general, and administrative expenses, before amortization, interest expense, restructuring charges, other charges (income), net, and taxes).
The following tables show the operations of the Company’s operating segments:
Three Months ended June 30, 2025
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Net sales to external customers
$
372,516
$
49,555
$
211,916
$
162,017
$
187,217
$
—
$
983,221
Net sales to other segments
39,173
199,323
50,547
83,316
9,520
(381,879)
—
Total net sales
411,689
248,878
262,463
245,333
196,737
(381,879)
983,221
Segment cost of sales(c)
187,249
116,806
114,982
110,991
107,634
Segment period expense(d)
$
131,740
$
61,491
$
95,601
$
45,004
$
58,000
Unallocated expense / eliminations
52,309
Segment profit
$
92,700
$
70,581
$
51,880
$
89,338
$
31,103
$
(52,309)
$
283,293
Six Months ended June 30, 2025
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Net sales to external customers
$
718,274
$
96,857
$
402,285
$
303,185
$
346,364
$
—
$
1,866,965
Net sales to other segments
73,266
375,829
95,634
160,392
17,686
(722,807)
—
Total net sales
791,540
472,686
497,919
463,577
364,050
(722,807)
1,866,965
Segment cost of sales(c)
350,171
219,030
219,049
210,469
195,104
Segment period expense(d)
$
264,373
$
122,080
$
183,945
$
87,753
$
113,352
Unallocated expense / eliminations
104,419
Segment profit
$
176,996
$
131,576
$
94,925
$
165,355
$
55,594
$
(104,419)
$
520,027
(a)Other includes reporting units in Eastern Europe, Latin America, Southeast Asia and other countries.
(b)Eliminations and Corporate includes the elimination of inter-segment transactions and certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
(c)Segment cost of sales includes variable production and other costs.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
(d)Segment period expense includes certain manufacturing, field service costs, research and development, and selling, general and administrative costs.
Three Months ended June 30, 2024
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Net sales to external customers
$
362,215
$
50,185
$
202,313
$
164,384
$
167,653
$
—
$
946,750
Net sales to other segments
36,017
169,194
42,171
81,894
7,604
(336,880)
—
Total net sales
398,232
219,379
244,484
246,278
175,257
(336,880)
946,750
Segment cost of sales(c)
171,894
104,181
111,223
102,788
95,694
Segment period expense(d)
$
126,091
$
59,394
$
88,137
$
43,994
$
54,935
Unallocated expense / eliminations
41,198
Segment profit
$
100,247
$
55,804
$
45,124
$
99,496
$
24,628
$
(41,198)
$
284,101
Six Months ended June 30, 2024
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Net sales to external customers
$
708,338
$
104,435
$
417,078
$
307,582
$
335,266
$
—
$
1,872,699
Net sales to other segments
73,435
392,565
89,909
162,536
10,936
(729,381)
—
Total net sales
781,773
497,000
506,987
470,118
346,202
(729,381)
1,872,699
Segment cost of sales(c)
338,218
263,176
235,200
207,990
190,505
Segment period expense(d)
$
249,672
$
118,934
$
176,352
$
86,809
$
105,887
Unallocated expense / eliminations
77,908
Segment profit
$
193,883
$
114,890
$
95,435
$
175,319
$
49,810
$
(77,908)
$
551,429
(a)Other includes reporting units in Eastern Europe, Latin America, Southeast Asia and other countries.
(b)Eliminations and Corporate includes the elimination of inter-segment transactions and certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
(c)Segment cost of sales includes variable production and other costs.
(d)Segment period expense includes certain manufacturing, field service costs, research and development, and selling, general and administrative costs.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
A reconciliation of earnings before taxes to segment profit for the three and six month periods ended June 30 follows:
Three Months Ended
Six Months Ended
2025
2024
2025
2024
Segment profit
$
283,293
$
284,101
$
520,027
$
551,429
Amortization
(17,581)
(18,178)
(34,774)
(36,406)
Interest expense
(16,779)
(18,950)
(33,432)
(38,182)
Restructuring charges
(3,557)
(5,329)
(7,324)
(14,993)
Other income, net
3,281
1,533
6,102
1,876
Earnings before taxes
$
248,657
$
243,177
$
450,599
$
463,724
The following tables show the additional disclosures for the Company’s reportable segments:
Three Months ended June 30, 2025
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Depreciation
$
4,150
$
1,681
$
1,472
$
2,331
$
1,636
$
1,600
$
12,870
Total assets
$
4,201,913
$
4,465,399
$
1,644,299
$
1,005,376
$
442,946
$
(8,359,468)
$
3,400,465
Purchase of property, plant, and equipment
$
(3,506)
$
(1,579)
$
(1,232)
$
(2,658)
$
(1,393)
$
(13,509)
$
(23,877)
Goodwill
$
532,394
$
28,920
$
108,380
$
611
$
13,817
$
—
$
684,122
Six Months ended June 30, 2025
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Depreciation
$
8,321
$
3,346
$
2,800
$
4,659
$
3,117
$
3,091
$
25,334
Purchase of property, plant, and equipment
$
(5,804)
$
(2,282)
$
(2,429)
$
(4,375)
$
(2,702)
$
(23,540)
$
(41,132)
(a)Other Operations includes reporting units in Southeast Asia, Latin America, Eastern Europe, and other countries.
(b)Eliminations and Corporate includes the elimination of intersegment transactions as well as certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
Three Months ended June 30, 2024
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Depreciation
$
4,165
$
1,712
$
1,339
$
2,358
$
1,298
$
1,479
$
12,351
Total assets
$
3,964,868
$
3,510,367
$
1,526,309
$
1,080,807
$
402,882
$
(7,236,069)
$
3,249,164
Purchase of property, plant, and equipment
$
(3,296)
$
(1,903)
$
(1,666)
$
(1,720)
$
(1,287)
$
(13,880)
$
(23,752)
Goodwill
$
526,385
$
25,841
$
99,401
$
601
$
13,131
$
—
$
665,359
Six Months ended June 30, 2024
U.S. Operations
Swiss Operations
Western European Operations
Chinese Operations
Other Operations(a)
Eliminations and Corporate(b)
Total
Depreciation
$
8,326
$
3,481
$
2,667
$
4,740
$
2,658
$
3,001
$
24,873
Purchase of property, plant, and equipment
$
(7,721)
$
(2,985)
$
(2,658)
$
(2,817)
$
(2,972)
$
(22,048)
$
(41,201)
(a)Other Operations includes reporting units in Southeast Asia, Latin America, Eastern Europe, and other countries.
(b)Eliminations and Corporate includes the elimination of intersegment transactions as well as certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
14. COMMITMENTS AND CONTINGENCIES
The Company is party to various legal proceedings, including certain environmental matters, incidental to the normal course of business. Management does not expect that any of such proceedings, either individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.
General
Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year ending December 31, 2025.
Changes in local currencies exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.
We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.
The following tables set forth certain items from our interim consolidated statements of operations and comprehensive income for the three and six month periods ended June 30, 2025 and 2024 (amounts in thousands).
Three months ended June 30,
Six months ended June 30,
2025
2024
2025
2024
(unaudited)
%
(unaudited)
%
(unaudited)
%
(unaudited)
%
Net sales
$
983,221
100.0
$
946,750
100.0
$
1,866,965
100.0
$
1,872,699
100.0
Cost of sales
403,345
41.0
381,082
40.3
761,210
40.8
758,898
40.5
Gross profit
579,876
59.0
565,668
59.7
1,105,755
59.2
1,113,801
59.5
Research and development
49,285
5.0
45,771
4.8
95,631
5.1
92,186
4.9
Selling, general and administrative
247,298
25.2
235,796
24.9
490,097
26.3
470,186
25.1
Amortization
17,581
1.8
18,178
1.9
34,774
1.8
36,406
1.9
Interest expense
16,779
1.7
18,950
2.0
33,432
1.8
38,182
2.0
Restructuring charges
3,557
0.3
5,329
0.6
7,324
0.4
14,993
0.8
Other charges (income), net
(3,281)
(0.3)
(1,533)
(0.2)
(6,102)
(0.3)
(1,876)
—
Earnings before taxes
248,657
25.3
243,177
25.7
450,599
24.1
463,724
24.8
Provision for taxes
46,309
4.7
21,363
2.3
84,664
4.5
64,401
3.5
Net earnings
$
202,348
20.6
$
221,814
23.4
$
365,935
19.6
$
399,323
21.3
Recent developments in global trade disputes/tariffs
In 2025, the U.S. government enacted incremental tariffs of 10% on imported products as well as higher tariffs on imports from certain other countries, including an additional 145% tariff on imports from China that has been recently reduced to 30%, a 25% tariff on non-USMCA products imported from Mexico, a 10% tariff on products imported from Switzerland that has recently been increased to 39%, and a 10% tariff on imports from the European Union that has recently increased to 15%. In response to the U.S. tariffs, the Chinese government implemented an additional tariff of 125% on imports from the U.S. that has recently been reduced to 10%. All the above-referenced tariffs became effective at various points during 2025, especially in April 2025.
We estimate the associated annualized cost increase of the incremental 2025 tariffs is approximately $95 million (assuming the above-referenced tariff rates). The U.S. government has indicated it may make further changes to tariff rates in the future. We are implementing various actions to mitigate the effect of the tariffs.
The recent escalation in global trade disputes/tariffs has increased economic uncertainty in
our end markets and the global economic environment, including increasing the risk of recession in many countries, and market conditions may change quickly. Although we are implementing various actions to mitigate the effect of the tariffs, they could adversely impact our financial results and could have a greater impact on our operating results in future periods. Please refer to Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 for more information.
Net sales
Net sales were $983.2 million and $946.8 million for the three months ended June 30, 2025, and 2024, respectively, and $1.9 billion for both six month periods ended June 30, 2025 and 2024. Sales in U.S. dollars increased 4% for the three month period and were flat for the six month period ended June 30, 2025. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 2% for the three month period and were flat for the six month period ended June 30, 2025. We estimate that net sales growth for the six months ended June 30, 2025 was reduced approximately 3% from the recovery of previously disclosed shipping delays during the three months ended March 31, 2024 related to a new external European logistics service provider.
Excluding this impact, sales increased 3% in local currency for the six months ended June 30, 2025 compared to the corresponding period in 2024.
We continue to benefit from the execution of our global sales and marketing programs, our innovative product portfolio, and investments in our field organization, particularly surrounding digital tools and techniques. However, the recent escalation in global trade disputes/tariffs has increased uncertainty in our end markets and the global economic environment, including increasing the risk of recession in many countries, and market conditions may change quickly. The ongoing developments related to global trade disputes/tariffs, Ukraine, and the conflict in the Middle East also present several risks to our business as further described in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024. These topics could adversely impact our financial results and could have a greater impact on our operating results in future periods.
Net sales by geographic destination for the three months ended June 30, 2025 in U.S. dollars increased 2% in the Americas, 6% in Europe, and 4% Asia/Rest of World. In local currencies, our net sales by geographic destination increased 3% in both the Americas and Asia/Rest of World, and were flat in Europe. Our net sales by geographic destination for the six months ended June 30, 2025 in U.S. dollars were flat in both the Americas and Asia/Rest of World, and decreased 2% in Europe. Net sales by geographic destination for the six months ended June 30, 2025 in local currencies increased 1% in both the Americas and Asia/Rest of World, and decreased 3% in Europe. Net sales in Asia/Rest of World in local currency includes decreases of 2% and 1% in China during the three and six months ended June 30, 2025. Excluding the impact of the recovery of delayed shipments in the prior year, local currency sales during the six months ended June 30, 2025 increased 3% in the Americas, 2% in Europe, and 3% in Asia/Rest of World, with sales flat in China. A discussion of sales by operating segment is included below.
As described in Note 18 to our consolidated financial statements for the year ended December 31, 2024, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.
Net sales of products increased 3% in U.S. dollars and 2% in local currencies for the three months ended June 30, 2025 and decreased 2% in both U.S. dollars and local currencies for the six months ended June 30, 2025, compared to the corresponding periods in 2024. Service revenue (including spare parts) increased 6% in U.S. dollars and 4% in local currencies for the three months ended June 30, 2025 and increased 5% in both U.S. dollars and local currencies for the six months ended June 30, 2025, compared to the corresponding periods in 2024.
Net sales of our laboratory products and services, which represented approximately 56% of our total net sales, increased 3% in U.S. dollars and 1% in local currencies for the three months ended June 30, 2025, and decreased 1% in both U.S. dollars and local currencies for the six months ended June 30, 2025. Laboratory net sales growth for the six months ended June 30, 2025 was reduced by approximately 4% from the recovery of previously disclosed shipping delays during the six month period ended June 30, 2024. The local currency increase in net sales of our laboratory-related products for the three and six months ended June 30, 2025 includes modest growth in most product categories. The six months ended June 30, 2025 also includes strong growth in process analytics.
Net sales of our industrial products and services, which represented approximately 39% of our total net sales, increased 5% in U.S. dollars and 4% in local currencies for the three months ended June 30, 2025, and increased 1% in U.S. dollars and 2% in local currencies for the six months ended June 30, 2025. Industrial net sales growth for the six months ended June 30, 2025 was reduced by approximately 1% from the recovery of previously disclosed shipping delays during the six month period ended June 30, 2024. The local currency increase in net sales of our industrial-related products for the three and six months ended June 30, 2025 includes strong growth in product inspection.
Net sales in our food retailing products and services, which represented approximately 5% of our total net sales, increased 3% in U.S. dollars and were flat in local currencies for the three months ended June 30, 2025, and decreased 5% in U.S. dollars and decreased 6% in local currencies for the six months ended June 30, 2025. Retail net sales growth for the six months ended June 30, 2025 was reduced by approximately 4% from the recovery of the previously disclosed shipping delays during the six month period ended June 30, 2024. The local currency net sales of our food retailing products for the three and six months ended June 30, 2025 are impacted by the timing of customer project activity.
Gross profit
Gross profit as a percentage of net sales was 59.0% and 59.7% for the three months ended June 30, 2025 and 2024, respectively, and 59.2% and 59.5% for the six months ended June 30, 2025 and 2024, respectively.
Gross profit as a percentage of net sales for products was 60.6% and 62.0% for the three months ended June 30, 2025 and 2024, respectively, and 61.1% and 61.6% for the six months ended June 30, 2025 and 2024, respectively.
Gross profit as a percentage of net sales for services (including spare parts) was 54.2% and 52.9% for the three months ended June 30, 2025 and 2024, respectively, and 54.0% and 52.9% for the six months ended June 30, 2025 and 2024, respectively.
The decrease in gross profit as a percentage of net sales for the three and six months ended June 30, 2025 primarily reflects increased tariff costs, partially offset by favorable price realization and benefits from our SternDrive program. The decrease in gross profit as a percentage of net sales for the six months ended June 30, 2025 also includes lower sales volume related to the recovery of shipping delays in the prior year.
The escalation in global trade disputes/tariffs may negatively impact our gross margins during the remainder of 2025. As previously mentioned, we have implemented various actions to mitigate the effect of the tariffs.
Research and development and selling, general and administrative expenses
Research and development expenses as a percentage of net sales was 5.0% and 4.8% for the three months ended June 30, 2025 and 2024, respectively, and was 5.1% and 4.9%for the six months ended June 30, 2025 and 2024, respectively. Research and development expenses increased 8% in U.S. dollars and 3% in local currencies for the three months ended June 30, 2025, and increased 4% in U.S. dollars and 3%in local currencies for the six months ended June 30, 2025, respectively, compared to the corresponding periods in 2024.
Selling, general and administrative expenses as a percentage of net sales were 25.2% and 24.9% for the three months ended June 30, 2025 and 2024, respectively, and were 26.3% and 25.1% for the six months ended June 30, 2025 and 2024, respectively. Selling, general and administrative expenses increased 5% in U.S. dollars and 2% in local currencies for the three months ended June 30, 2025, and increased 4% in U.S. dollars and local currencies for the six months ended June 30, 2025. The local currency increase for the three and six months ended June 30, 2025 includes sales and marketing investments, offset in part by savings from our cost savings initiatives and lower variable compensation.
Amortization, interest expense, restructuring charges, other charges (income), net and taxes
Amortization expense was $17.6 million and $18.2 million for the three months ended June 30, 2025 and 2024, respectively, and $34.8 million and $36.4 million for the six months ended June 30, 2025 and 2024, respectively.
Interest expense was $16.8 million and $19.0 million for the three months ended June 30, 2025 and 2024, respectively, and $33.4 million and $38.2 million for the six months ended June 30, 2025 and 2024, respectively.
Restructuring charges were $3.6 million and $5.3 million for the three months ended June 30, 2025 and 2024, respectively, and $7.3 million and $15.0 million for the six months ended June 30, 2025 and 2024, respectively. Restructuring expenses are primarily comprised of employee-related costs.
Other charges (income), net includes non-service pension costs (benefits), net (gains) losses from foreign currency transactions and hedging activities, interest income and other items. Non-service pension benefits were $3.4 million and $1.9 million for the three months ended June 30, 2025 and 2024, respectively, and $6.5 million and $3.8 million for the six months ended June 30, 2025 and 2024, respectively.
Our reported tax rate was 18.6% and 8.8% during the three months ended June 30, 2025 and 2024, respectively, and 18.8% and 13.9% during the six months ended June 30, 2025 and 2024, respectively. The reported tax rate for the three and six month periods ended June 30, 2024 includes a non-cash discrete tax benefit of $23.0 million resulting from the reduction of uncertain tax position liabilities related to the settlement of a tax audit. The provision for taxes is based upon our projected annual effective tax rate of 19.0% before non-recurring discrete tax items for the periods ended June 30, 2025 and 2024. The difference between our projected annual effective tax rate and the reported tax rate is related to the timing of excess tax benefits associated with stock option exercises and the non-recurring discrete tax item in the prior year.
On July 4, 2025, the United States enacted new tax legislation into law. We are currently evaluating the impact of the new legislation on our consolidated financial statements and we do not expect a significant impact on our projected annual tax rate.
The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 18 to our consolidated financial statements for the year ended December 31, 2024.
U.S. Operations (amounts in thousands)
Three months ended June 30,
Six months ended June 30,
2025
2024
%
2025
2024
%
Net sales to external customers
$
372,516
$
362,215
3%
$
718,274
$
708,338
1%
Net sales to other segments
39,173
36,017
9%
73,266
73,435
—%
Segment net sales
411,689
398,232
3%
791,540
781,773
1%
Segment cost of sales
187,249
171,894
9%
350,171
338,218
4%
Segment period expense
131,740
126,091
4%
264,373
249,672
6%
Segment profit
$
92,700
$
100,247
(8)%
$
176,996
$
193,883
(9)%
Total net sales and net sales to external customers increased 3% and 1%for the three and six months ended June 30, 2025, respectively, compared with the corresponding periods in 2024. The growth in net sales to external customers during the six months ended June 30, 2025 was reduced approximately 2% from the recovery of previously disclosed shipping delays during the six month period ended June 30, 2024. Net sales to external customers for the three and six months ended June 30, 2025 includes strong growth in product inspection and process analytics.
Segment profit decreased $7.5 millionand $16.9 millionfor the three and six months ended June 30, 2025, compared to the corresponding periods in 2024. Segment profit during the three months ended June 30, 2025 includes higher tariff costs and unfavorable business mix, offset in part by favorable price realization. Segment profit during the six months ended June 30, 2025 was also negatively impacted by lower sales volume in the first quarter related to the previously disclosed shipping delay recovery in the prior year.
Swiss Operations (amounts in thousands)
Three months ended June 30,
Six months ended June 30,
2025
2024
%1)
2025
2024
%1)
Net sales to external customers
$
49,555
$
50,185
(1)%
$
96,857
$
104,435
(7)%
Net sales to other segments
199,323
169,194
18%
375,829
392,565
(4)%
Segment net sales
248,878
219,379
13%
472,686
497,000
(5)%
Segment cost of sales
116,806
104,181
12%
219,030
263,176
(17)%
Segment period expense
61,491
59,394
4%
122,080
118,934
3%
Segment profit
$
70,581
$
55,804
26%
$
131,576
$
114,890
15%
1)Represents U.S. dollar growth (decline).
Total net sales increased 13% in U.S. dollars and 5% in local currency for the three months ended June 30, 2025, and decreased 5% in U.S. dollars and decreased 7% in local currency for the six months ended June 30, 2025, respectively, compared to the corresponding periods in 2024. Net sales to external customers decreased 1% in U.S. dollars and decreased 6% in local currency for the three months ended June 30, 2025 and decreased 7% in U.S. dollars and decreased 9% in local currency for the six months ended June 30, 2025, compared to the corresponding periods in 2024. The decline in net sales to external customers during the six months ended June 30, 2025 includes a 6% decline from the recovery of previously disclosed shipping delays during the six months ended
June 30, 2024. Net sales to external customers for the three and six months ended June 30, 2025 includes a decline in most product categories.
Segment profit increased $14.8 million and $16.7 millionfor the three and six months ended June 30, 2025, respectively, compared to the corresponding periods in 2024. Segment profit increased during the three months ended June 30, 2025 primarily due to higher net sales to other segments, offset in part by unfavorable foreign currency translation.
Western European Operations (amounts in thousands)
Three months ended June 30,
Six months ended June 30,
2025
2024
%1)
2025
2024
%1)
Net sales to external customers
$
211,916
$
202,313
5%
$
402,285
$
417,078
(4)%
Net sales to other segments
50,547
42,171
20%
95,634
89,909
6%
Segment net sales
262,463
244,484
7%
497,919
506,987
(2)%
Segment cost of sales
114,982
111,223
3%
219,049
235,200
(7)%
Segment period expense
95,601
88,137
8%
183,945
176,352
4%
Segment profit
$
51,880
$
45,124
15%
$
94,925
$
95,435
(1)%
1)Represents U.S. dollar growth (decline).
Total net sales increased 7% in U.S. dollars and 2% in local currencies for the three months ended June 30, 2025 and decreased 2% in U.S. dollars and decreased 3% in local currencies for the six months ended June 30, 2025, compared to the corresponding periods in 2024. Net sales to external customers increased 5% in U.S. dollars and decreased 1% in local currencies for the three months ended June 30, 2025, and decreased 4% in U.S. dollars and decreased 5% in local currencies for the six months ended June 30, 2025, compared to the corresponding periods in 2024. The growth in net sales to external customers during the six months ended June 30, 2025 was reduced approximately 5% from the recovery of previously disclosed shipping delays during the six month period ended June 30, 2024. Net sales to external customers for the three months ended June 30, 2025 includes a modest decline in laboratory-related products.
Segment profit increased $6.8 millionand decreased $0.5 million for the three and six month periods ended June 30, 2025, respectively, compared to the corresponding periods in 2024. The increase in segment profit during the three months ended June 30, 2025 includes increased net sales and benefits from our margin expansion initiatives, as well as favorable foreign currency translation. The decrease in segment profit during the six months ended June 30, 2025 reflects lower sales volume related to our previously disclosed shipping delay recovery in the prior year.
Chinese Operations (amounts in thousands)
Three months ended June 30,
Six months ended June 30,
2025
2024
%1)
2025
2024
%1)
Net sales to external customers
$
162,017
$
164,384
(1)%
$
303,185
$
307,582
(1)%
Net sales to other segments
83,316
81,894
2%
160,392
162,536
(1)%
Segment net sales
245,333
246,278
—%
463,577
470,118
(1)%
Segment cost of sales
110,991
102,788
8%
210,469
207,990
1%
Segment period expense
45,004
43,994
2%
87,753
86,809
1%
Segment profit
$
89,338
$
99,496
(10)%
$
165,355
$
175,319
(6)%
1)Represents U.S. dollar growth (decline).
Total net sales were flat in U.S. dollars and decreased 1% in local currency for the three months ended June 30, 2025 and decreased 1%in both U.S. dollars and local currency for the six months ended June 30, 2025, compared to the corresponding periods in 2024. Net sales to external
customers decreased 1% in U.S. dollars and decreased 2% in local currency by origin for the three months ended June 30, 2025 and decreased 1% in both U.S. dollars and local currency during the six months ended June 30, 2025, compared to the corresponding periods in 2024. The growth in net sales to external customers during the six months ended June 30, 2025 was reduced approximately 1% from the recovery of previously disclosed shipping delays during the six month period ended June 30, 2024. Net sales to external customers for the three months ended June 30, 2025 includes a decline in laboratory-related products.
Segment profit decreased $10.2 million and $10.0 millionfor the three and six month periods ended June 30, 2025, respectively, compared to the corresponding periods in 2024. The decrease in segment profit during the three and six months ended June 30, 2025 includes lower sales volume and increased tariff costs, offset in part by benefits from our cost savings initiatives.
Other (amounts in thousands)
Three months ended June 30,
Six months ended June 30,
2025
2024
%1)
2025
2024
%1)
Net sales to external customers
$
187,217
$
167,653
12%
$
346,364
$
335,266
3%
Net sales to other segments
9,520
7,604
25%
17,686
10,936
62%
Segment net sales
196,737
175,257
12%
364,050
346,202
5%
Segment cost of sales
107,634
95,694
12%
195,104
190,505
2%
Segment period expense
58,000
54,935
6%
113,352
105,887
7%
Segment profit
$
31,103
$
24,628
26%
$
55,594
$
49,810
12%
1)Represents U.S. dollar growth (decline).
Total net sales increased 12% in U.S. dollars and 11% in local currency for the three months ended June 30, 2025 and increased 5% in U.S. dollars and 7% in local currency for the six months ended June 30, 2025, compared to the corresponding periods in 2024. Net sales to external customers increased 12% in U.S. dollars and 11% in local currencies for the three months ended June 30, 2025 and increased 3% in U.S. dollars and 5% in local currencies for the six months ended June 30, 2025, compared to the corresponding periods in 2024. The growth in net sales to external customers during the six months ended June 30, 2025 was reduced approximately 5% from the recovery of previously disclosed shipping delays during the six months ended June 30, 2024. Net sales to external customers for the three and six months ended June 30, 2025 includes strong growth in most product categories, particularly laboratory-related products.
Segment profit increased $6.5 million and $5.8 millionfor the three and six months ended June 30, 2025, respectively, compared to the corresponding periods in 2024. The increase in segment profit for the three and six months ended June 30, 2025 is primarily related to increased sales volume and benefits from our margin expansion initiatives.
Liquidity and Capital Resources
Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes available borrowings under our Credit Agreement, the ability to obtain appropriate financing and our cash and cash equivalent balances. Currently, our liquidity needs are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions. Global market conditions can be uncertain, and our ability to generate cash flows could be reduced by a deterioration in global markets.
We currently believe that cash flows from operating activities, together with liquidity available under our Credit Agreement, local working capital facilities, and cash balances, will be sufficient to fund currently anticipated working capital needs and spending requirements for at least the foreseeable future.
Cash provided by operating activities totaled $430.8 million during the six months ended June 30, 2025, compared to $447.5 million in the corresponding period in 2024. The decrease for the six months ended June 30, 2025 is primarily related to higher cash incentive payments of approximately $36 million related to prior year performance.
Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $41.1 million for the six months ended June 30, 2025 compared to $41.2 million in the corresponding period in 2024.
Cash flows used in financing activities are primarily comprised of share repurchases. In accordance with our share repurchase program, we spent $437.5 million and $425.0 million on the repurchase of 368,010 shares and 330,492 shares, during the six months ended June 30, 2025 and 2024, respectively.
Senior Notes and Credit Facility Agreement
Our debt consisted of the following at June 30, 2025:
U.S. Dollar
Other Principal Trading Currencies
Total
3.91% $75 million ten-year Senior Notes due June 25, 2029
75,000
—
75,000
5.45% $150 million ten-year Senior Notes due March 1, 2033
150,000
—
150,000
2.83% $125 million twelve-year Senior Notes due July 22, 2033
125,000
—
125,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035
50,000
—
50,000
2.81% $150 million fifteen-year Senior Note due March 17, 2037
150,000
—
150,000
2.91% $150 million fifteen-year Senior Note due September 1, 2037
150,000
—
150,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030
—
146,285
146,285
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034
—
157,987
157,987
1.06% Euro 125 million fifteen-year Senior Notes due March 19, 2036
—
146,285
146,285
3.80% Euro 100 million 10 1/2-year Senior Notes due July 9, 2035
—
117,028
117,028
Debt issuance costs, net
(2,206)
(1,858)
(4,064)
Total Senior Notes
697,794
565,727
1,263,521
$1.35 billion Credit Agreement, interest at benchmark plus 87.5 basis points (a)
437,637
414,432
852,069
Other local arrangements
9,243
59,089
68,332
Total debt
1,144,674
1,039,248
2,183,922
Less: current portion
(1,306)
(58,881)
(60,187)
Total long-term debt
$
1,143,368
$
980,367
$
2,123,735
(a) The benchmark interest rate is determined by the borrowing currency. The benchmark rates by borrowing currency are as follows: SOFR for U.S. dollars (plus a 10 basis points spread adjustment), SARON for Swiss franc, EURIBOR for Euro and SONIA for Great British pounds.
On May 30, 2024, we entered into a $1.35 billion Credit Agreement (the Credit Agreement), which amended our $1.25 billion Amended and Restated Credit Agreement (the Prior Credit Agreement), that is further described in Note 7 of our consolidated financial statements.
As of June 30, 2025, we had $493.4 million of additional borrowings available under our Credit Agreement, and we maintained $61.8 million of cash and cash equivalents.
Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.
Further, we do not have any downgrade triggers relating to ratings from rating agencies that would accelerate the maturity dates of our debt. We were in compliance with our debt covenants as of June 30, 2025.
In January 2025, we entered into an agreement to issue and sell EUR 100 million 10 1/2-year Senior Notes with a fixed interest rate of 3.8% (3.8% Euro Senior Notes) in a private placement, which will mature in July 2035. The 3.8% Euro Senior Notes are unsecured obligations of the Company and the terms are consistent with the previous Notes as disclosed in Note 10 to our consolidated financial statements for the year ended December 31, 2024. We used the proceeds from the sale of the Notes to refinance existing indebtedness and for other general corporate purposes.
Other Local Arrangements
In April 2018, two of our non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of SARON plus 87.5 basis points. The loans were renewed for one year in April 2025.
Share Repurchase Program
We have $1.3 billion of remaining availability for our share repurchase program as of June 30, 2025. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors.
We have purchased 32.7 million shares at an average price per share of $312.57 since the inception of the program in 2004 through June 30, 2025. During the six months ended June 30, 2025 and 2024, we spent $437.5 million and $425.0 million on the repurchase of 368,010 and 330,492 shares at an average price per share of $1,188.80 and $1,285.94, respectively. We also reissued 17,589 shares and 23,538 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the six months ended June 30, 2025 and 2024, respectively. In addition, we incurred $2.1 million and $1.9 million of excise tax during the three months ended June 30, 2025 and 2024, respectively, and $4.1 million and $4.0 million of excise tax during the six months ended June 30, 2025 and 2024, respectively related to the Inflation Reduction Act which is reflected as a reduction in shareholders' equity in our consolidated financial statements.
Effect of Currency on Results of Operations
Our earnings are affected by changes in exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, Chinese renminbi, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings decrease. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also decrease. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $2.6 million to $2.9 million annually.
We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese renminbi. The impact on our earnings before tax of the Chinese renminbi weakening 1% against the U.S. dollar is a reduction of approximately $2.1 million to $2.4 million annually.
- 35 -
In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar, the Swiss franc and the euro. Based on our outstanding debt at June 30, 2025, we estimate that a 5% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $54.8 million in the reported U.S. dollar value of our debt.
Forward-Looking Statements Disclaimer
You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, and the conflicts in Ukraine and the Middle East. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” or “continue.”
We make forward-looking statements in this Quarterly Report about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, and the conflicts in Ukraine and the Middle East on our business.
Our forward-looking statements may not be accurate or complete, speak only as of the date of this Quarterly Report, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, inflation, and the ongoing conflicts in Ukraine and the Middle East. See in particular “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2024 and other reports filed with the SEC from time to time.
Item 3.Quantitative and Qualitative Disclosures About Market Risk
As of June 30, 2025, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Item 4.Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
For the three and six months ended June 30, 2025 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
(a)
(b)
(c)
(d)
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Program
Approximate Dollar Value (in thousands) of Shares that may yet be Purchased under the Program
April 1 to April 30, 2025
70,935
$
1,045.20
70,935
$
1,415,543
May 1 to May 31, 2025
69,260
$
1,123.97
69,260
$
1,337,695
June 1 to June 30, 2025
56,858
$
1,174.09
56,858
$
1,270,937
Total
197,053
$
1,110.08
197,053
$
1,270,937
The Company has $1.3 billion of remaining availability as of June 30, 2025. The Company have purchased 32.7 million shares at an average price per share of $312.57 since the inception of the program through June 30, 2025.
During the six months ended June 30, 2025 and 2024, the Company spent $437.5 million and $425.0 million on the repurchase of 368,010 and 330,492 shares at an average price per share of $1,188.80 and $1,285.94, respectively. The Company also reissued 17,589 shares and 23,538 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the six months ended June 30, 2025 and 2024, respectively. In addition, the Company incurred $2.1 million and $1.9 million of excise tax during the three months ended June 30, 2025 and 2024, respectively, and $4.1 million and $4.0 million of excise tax during the six months ended June 30, 2025 and 2024, respectively related to the Inflation Reduction Act which is reflected as a reduction in shareholders' equity in the Company's consolidated financial statements.
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.